These results suggest that the role of LGALS9 in CRC may depend on CD137 expression, highlighting the potential of LGALS9 as a therapeutic target. CD137 levels may serve as a key indicator for predicting the effectiveness of this treatment strategy.
17 days ago
Journal • IO biomarker
|
TNFRSF9 (TNF Receptor Superfamily Member 9) • LGALS9 (Galectin 9)